Altimmune, Inc. (ALT) vs Delcath Systems, Inc. (DCTH)
A side-by-side comparison of Altimmune, Inc. and Delcath Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALT
Altimmune, Inc.
$2.68HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
DCTH
Delcath Systems, Inc.
$15.68HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ALT vs DCTH
growth of $100 · dividends reinvested · last 8yALT -87.0% (-22.5%/yr)DCTH -98.3% (-40.0%/yr)ALT compounded faster over this window
Log scale — wide-divergence pair
ALT DCTH
ALT vs DCTH: by the numbers
- •DCTH is the larger company ($541M vs $520M market cap).
- •DCTH is profitable (0.56% net margin) while ALT runs a net loss (-296000.00%).
- •DCTH grew revenue faster over the past five years (118.96% vs -65.38% CAGR).
Metrics side by side
Valuation
| Metric | ALT | DCTH |
|---|---|---|
| P/E ratio | N/A | 1206.15 |
| P/S ratio | 16781.22 | 5.67 |
| P/B ratio | 1.10 | 4.47 |
| FCF yield | N/A | 3.23% |
Profitability
| Metric | ALT | DCTH |
|---|---|---|
| Gross margin | 100.00% | 87.05% |
| Operating margin | -230460.98% | -1.90% |
| Net margin | -296000.00% | 0.56% |
| ROE | -19.35% | 0.44% |
| ROIC | -19.47% | -0.81% |
Growth (annualized)
| Metric | ALT | DCTH |
|---|---|---|
| Revenue CAGR (5Y) | -65.38% | 118.96% |
| Total return CAGR (5Y) | -25.30% | 10.90% |
Frequently asked
- Which has grown faster, ALT or DCTH?
- Over the past five years, DCTH grew revenue faster — ALT at a -65.38% CAGR versus DCTH at 118.96%.
- Is ALT or DCTH more profitable?
- DCTH runs the higher net margin — ALT at -296000.00% versus DCTH at 0.56%.
- How have ALT and DCTH total returns compared?
- Over the past 5 years, ALT delivered -25.30% and DCTH delivered 10.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Delcath Systems P/E ratioAltimmune ROEDelcath Systems ROEAltimmune operating marginDelcath Systems operating marginAltimmune revenue growthDelcath Systems revenue growthAltimmune free cash flowDelcath Systems free cash flow
Altimmune & Delcath Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.